Two Sigma Securities, LLC Infla Rx N.V. Transaction History

Two Sigma Securities, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$1.18 - $1.74 $14,242 - $21,001	12,070 New	12,070 $21,000
Q4 2021 Feb 14, 2022	SELL	$2.35 - $5.58 $52,999 - $125,845	-22,553 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$2.25 - $3.03 $50,744 - $68,335	22,553 New	22,553 $58,000
Q3 2019 Nov 14, 2019	SELL	$2.47 - $3.51 $43,738 - $62,155	-17,708 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$3.06 - $51.61 $54,186 - $913,909	17,708 New	17,708 $56,000

12.9M

19.3K

Ticker IFRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 44,203,800
Market Cap $77.4M
Description
InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a nov...

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Securities, LLC with notifications on news.